BioNxt Solutions Inc. (FRA:BXT)
Germany flag Germany · Delayed Price · Currency is EUR
0.4080
+0.0280 (7.37%)
At close: Jan 30, 2026

BioNxt Solutions Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-6.18-5.31-7.72-12.38-20.64-16.89
Depreciation & Amortization
0.030.090.20.210.820.89
Other Amortization
---0.010.010.01
Loss (Gain) From Sale of Assets
-0.02-0.05--0.02
Asset Writedown & Restructuring Costs
--0.055.893.681.96
Stock-Based Compensation
1.540.60.640.113.853.42
Provision & Write-off of Bad Debts
--00.02--
Other Operating Activities
0.720.791.140.470.550.37
Change in Accounts Receivable
-0.060.220.170.07-0.21-0.18
Change in Inventory
---0.13-0.74-
Change in Accounts Payable
-1.30.650.13-0.730.460.22
Change in Other Net Operating Assets
0.08-0.090.18-0.030.08-0.01
Operating Cash Flow
-5.18-3.03-5.17-6.23-12.16-10.2
Capital Expenditures
---0.2-0-0.45-0.16
Sale of Property, Plant & Equipment
0.130.060.3---
Cash Acquisitions
-----4.86-
Other Investing Activities
-0.05-----
Investing Cash Flow
0.080.060.1-0-5.31-0.16
Long-Term Debt Issued
-2.11-2.582.34.63
Long-Term Debt Repaid
--1.03-0.25-3.55-0.42-0.4
Net Debt Issued (Repaid)
4.011.08-0.25-0.961.874.23
Issuance of Common Stock
2.061.855.996.4614.958.42
Other Financing Activities
-0.58-0.28-0.45-0.47-0.59-
Financing Cash Flow
5.492.645.295.0216.2312.65
Foreign Exchange Rate Adjustments
000-0-00
Net Cash Flow
0.39-0.330.23-1.22-1.232.29
Free Cash Flow
-5.18-3.03-5.37-6.23-12.61-10.36
Free Cash Flow Margin
-32769.02%-11243.72%-1442.32%-2095.73%-4400.52%-2997.63%
Free Cash Flow Per Share
-0.04-0.03-0.05-0.07-0.18-0.18
Levered Free Cash Flow
-4.010.01-3.51-4.65-5.92-5.05
Unlevered Free Cash Flow
-3.20.63-2.86-3.94-5.46-4.86
Change in Working Capital
-1.280.790.48-0.56-0.420.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.